The Prognostic Significance of p16 Status in Patients With Vulvar Cancer Treated With Vulvectomy and Adjuvant Radiation.

[1]  N. Rydzewski,et al.  Role of adjuvant external beam radiotherapy and chemotherapy in one versus two or more node-positive vulvar cancer: A National Cancer Database study. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  P. Bult,et al.  Vulvar cancer: Two pathways with different localization and prognosis. , 2018, Gynecologic oncology.

[3]  H. Mackay,et al.  Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

[4]  F. L. Sand,et al.  Does HPV status influence survival after vulvar cancer? , 2018, International journal of cancer.

[5]  J. Debus,et al.  Oral Scientific SessionsPrognostic Factors and Impact of HPV/p16ink4a Status on Survival in Vulvar Cancer Patients Treated with Radiation Therapy , 2017 .

[6]  A. Talhouk,et al.  Human papillomavirus (HPV)‐independent vulvar squamous cell carcinoma has a worse prognosis than HPV‐associated disease: a retrospective cohort study , 2017, Histopathology.

[7]  S. Kjaer,et al.  Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva , 2017, International journal of cancer.

[8]  H. Sekhon,et al.  Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3 , 2017, Clinical Cancer Research.

[9]  N. Reed,et al.  HPV status and favourable outcome in vulvar squamous cancer , 2017, International journal of cancer.

[10]  P. Catalano,et al.  Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy. , 2016, Gynecologic oncology.

[11]  J. McAlpine,et al.  p16 Immunostaining Allows for Accurate Subclassification of Vulvar Squamous Cell Carcinoma Into HPV-Associated and HPV-Independent Cases , 2016, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[12]  J. Lou,et al.  Prognostic Value of Overexpressed p16INK4a in Vulvar Cancer: A Meta-Analysis , 2016, PloS one.

[13]  Young Seok Kim,et al.  Treatment outcomes of curative radiotherapy in patients with vulvar cancer: results of the retrospective KROG 1203 study , 2015, Radiation oncology journal.

[14]  P. Harari,et al.  The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy. , 2015, Annals of translational medicine.

[15]  S. Beriwal,et al.  National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements. , 2014, International journal of radiation oncology, biology, physics.

[16]  E. Høgdall,et al.  Human papillomavirus genotyping and p16 expression as prognostic factors for patients with American Joint Committee on Cancer stages I to III carcinoma of the anal canal. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  R. Berkowitz,et al.  Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. , 2013, Gynecologic oncology.

[18]  T. Grob,et al.  HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  F. Elgh,et al.  Human Papillomavirus (HPV) and HPV 16–Variant Distribution in Vulvar Squamous Cell Carcinoma in Sweden , 2012, International Journal of Gynecologic Cancer.

[20]  J. Ordi,et al.  Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma? , 2011, Gynecologic oncology.

[21]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[22]  H. Jacobsson,et al.  Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node. , 2010, Gynecologic oncology.

[23]  C. Tian,et al.  Radiation Therapy Compared With Pelvic Node Resection for Node-Positive Vulvar Cancer: A Randomized Controlled Trial , 2009, Obstetrics and gynecology.

[24]  J. Pintos,et al.  Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. , 2004, Gynecologic oncology.

[25]  M. Urrutia Ruiz.  Vulvar cancer , 1994 .

[26]  N. Hacker,et al.  Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. , 1990 .

[27]  B. Bundy,et al.  Radiation Therapy Versus Pelvic Node Resection for Carcinoma of the Vulva With Positive Groin Nodes , 1986, Obstetrics and gynecology.

[28]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.